-
1
-
-
0025883958
-
The United States Renal Data System's 1991 annual data report: An introduction
-
Held P.J., Port F.K., Webb R.L., Wolfe R.A., Garcia J.R., Blagg C.R., Agodoa L.Y.: The United States Renal Data System's 1991 annual data report: an introduction. Am. J. Kidney Dis. 18: 1-16 (1991)
-
(1991)
Am. J. Kidney Dis
, vol.18
, pp. 1-16
-
-
Held, P.J.1
Port, F.K.2
Webb, R.L.3
Wolfe, R.A.4
Garcia, J.R.5
Blagg, C.R.6
Agodoa, L.Y.7
-
2
-
-
61649096404
-
Microalbuminuria - a biomarker of renal microvascular disease
-
Futrakul N., Sridama V., Futrakul P.: Microalbuminuria - a biomarker of renal microvascular disease. Ren. Fail. 31: 140-143 (2009)
-
(2009)
Ren. Fail
, vol.31
, pp. 140-143
-
-
Futrakul, N.1
Sridama, V.2
Futrakul, P.3
-
4
-
-
0021715307
-
Structural-functional relationships in diabetic nephropathy
-
Mauer S.M., Steffes M.W., Ellis E.N., Sutherland D.E., Brown D.M., Goetz F.C.: Structural-functional relationships in diabetic nephropathy. J. Clin. Invest. 74: 1143-1155 (1984)
-
(1984)
J. Clin. Invest
, vol.74
, pp. 1143-1155
-
-
Mauer, S.M.1
Steffes, M.W.2
Ellis, E.N.3
Sutherland, D.E.4
Brown, D.M.5
Goetz, F.C.6
-
5
-
-
0027378455
-
Glomerular structure and function in proteinuric type 2 (non-insulin-dependent) diabetic patients
-
Osterby R., Gall M.A., Schmitz A., Nielsen F.S., Nyberg G., Parving H.H.: Glomerular structure and function in proteinuric type 2 (non-insulin-dependent) diabetic patients. Diabetologia 36: 1064-1070 (1993)
-
(1993)
Diabetologia
, vol.36
, pp. 1064-1070
-
-
Osterby, R.1
Gall, M.A.2
Schmitz, A.3
Nielsen, F.S.4
Nyberg, G.5
Parving, H.H.6
-
6
-
-
0033843758
-
Type 2 diabetic patients with nephropathy show structural-functional relationships that are similar to type 1 disease
-
White K.E., Bilous R.W.: Type 2 diabetic patients with nephropathy show structural-functional relationships that are similar to type 1 disease. J. Am. Soc. Nephrol. 11: 1667-1673 (2000)
-
(2000)
J. Am. Soc. Nephrol
, vol.11
, pp. 1667-1673
-
-
White, K.E.1
Bilous, R.W.2
-
7
-
-
67049160811
-
New aspects of glomerular filtration barrier structure and function: Five layers (at least) not three
-
Salmon A.H., Neal C.R., Harper S.J.: New aspects of glomerular filtration barrier structure and function: five layers (at least) not three. Curr. Opin. Nephrol. Hypertens. 18: 197-205 (2009)
-
(2009)
Curr. Opin. Nephrol. Hypertens
, vol.18
, pp. 197-205
-
-
Salmon, A.H.1
Neal, C.R.2
Harper, S.J.3
-
8
-
-
41849137193
-
What is the mechanism of microalbuminuria in diabetes: A role for the glomerular endothelium?
-
Satchell S.C., Tooke J.E.: What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium? Diabetologia 51: 714-725 (2008)
-
(2008)
Diabetologia
, vol.51
, pp. 714-725
-
-
Satchell, S.C.1
Tooke, J.E.2
-
9
-
-
0026395163
-
The vascular endothelial growth factor family: Identification of a fourth molecular species and characterization of alternative splicing of RNA
-
Houck K.A., Ferrara N., Winer J., Cachianes G., Li B., Leung D.W.: The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol. Endocrinol. 5: 1806-1814 (1991)
-
(1991)
Mol. Endocrinol
, vol.5
, pp. 1806-1814
-
-
Houck, K.A.1
Ferrara, N.2
Winer, J.3
Cachianes, G.4
Li, B.5
Leung, D.W.6
-
10
-
-
0032907687
-
Vascular endothelial growth factor (VEGF) and its receptors
-
Neufeld G., Cohen T., Gengrinovitch S., Poltorak Z.: Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 13: 9-22 (1999)
-
(1999)
FASEB J
, vol.13
, pp. 9-22
-
-
Neufeld, G.1
Cohen, T.2
Gengrinovitch, S.3
Poltorak, Z.4
-
11
-
-
0037699955
-
Angiogenesis in health and disease
-
Carmeliet P.: Angiogenesis in health and disease. Nat. Med. 9: 653-660 (2003)
-
(2003)
Nat. Med
, vol.9
, pp. 653-660
-
-
Carmeliet, P.1
-
12
-
-
0035704913
-
The role of vascular endothelial growth factor in angiogenesis
-
Ferrara N., Gerber H.P.: The role of vascular endothelial growth factor in angiogenesis. Acta Haematol. 106: 148-156 (2001)
-
(2001)
Acta Haematol
, vol.106
, pp. 148-156
-
-
Ferrara, N.1
Gerber, H.P.2
-
13
-
-
0037098860
-
VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma
-
Bates D.O., Cui T.G., Doughty J.M., Winkler M., Sugiono M., Shields J.D., Peat D., Gillatt D., Harper S.J.: VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma. Cancer Res. 62: 4123-4131 (2002)
-
(2002)
Cancer Res
, vol.62
, pp. 4123-4131
-
-
Bates, D.O.1
Cui, T.G.2
Doughty, J.M.3
Winkler, M.4
Sugiono, M.5
Shields, J.D.6
Peat, D.7
Gillatt, D.8
Harper, S.J.9
-
14
-
-
27744489034
-
Diabetic retinopathy is associated with a switch in splicing from anti- to pro-angiogenic isoforms of vascular endothelial growth factor
-
Perrin R.M., Konopatskaya O., Qiu Y., Harper S., Bates D.O., Churchill A.J.: Diabetic retinopathy is associated with a switch in splicing from anti- to pro-angiogenic isoforms of vascular endothelial growth factor. Diabetologie 48: 2422-2427 (2005)
-
(2005)
Diabetologie
, vol.48
, pp. 2422-2427
-
-
Perrin, R.M.1
Konopatskaya, O.2
Qiu, Y.3
Harper, S.4
Bates, D.O.5
Churchill, A.J.6
-
15
-
-
0030054913
-
Similarities and differences between the vascular endothelial growth factor (VEGF) splice variants
-
Neufeld G., Cohen T., Gitay-Goren H., Poltorak Z., Tessler S., Sharon R., Gengrinovitch S., Levi B.Z.: Similarities and differences between the vascular endothelial growth factor (VEGF) splice variants. Cancer Metastasis Rev. 15: 153-158 (1996)
-
(1996)
Cancer Metastasis Rev
, vol.15
, pp. 153-158
-
-
Neufeld, G.1
Cohen, T.2
Gitay-Goren, H.3
Poltorak, Z.4
Tessler, S.5
Sharon, R.6
Gengrinovitch, S.7
Levi, B.Z.8
-
16
-
-
0037699954
-
The biology of VEGF and its receptors
-
Ferrara N., Gerber H.P., LeCouter J.: The biology of VEGF and its receptors. Nat. Med. 9: 669-676 (2003)
-
(2003)
Nat. Med
, vol.9
, pp. 669-676
-
-
Ferrara, N.1
Gerber, H.P.2
LeCouter, J.3
-
17
-
-
33646711885
-
The endogenous anti-angiogenic family of splice variants of VEGF, VEGFxxxb, are down-regulated in pre-eclamptic placentae at term
-
Bates D.O., MacMillan P.P., Manjaly J.G., Qiu Y., Hudson S.J., Bevan H.S., Hunter A.J., Soothill P.W., Read M., Donaldson L.F., Harper S.J.: The endogenous anti-angiogenic family of splice variants of VEGF, VEGFxxxb, are down-regulated in pre-eclamptic placentae at term. Clin Sci (Lond) 110: 575-585 (2006)
-
(2006)
Clin Sci (Lond)
, vol.110
, pp. 575-585
-
-
Bates, D.O.1
MacMillan, P.P.2
Manjaly, J.G.3
Qiu, Y.4
Hudson, S.J.5
Bevan, H.S.6
Hunter, A.J.7
Soothill, P.W.8
Read, M.9
Donaldson, L.F.10
Harper, S.J.11
-
18
-
-
42149152015
-
VEGF 165 b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: Balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy
-
Varey A.H., Rennel E.S., Qiu Y., Bevan H.S., Perrin R.M., Raffy S., Dixon A.R., Paraskeva C., Zaccheo O., Hassan A.B., Harper S.J., Bates D.O.: VEGF 165 b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy. Br. J. Cancer 98: 1366-1379 (2008)
-
(2008)
Br. J. Cancer
, vol.98
, pp. 1366-1379
-
-
Varey, A.H.1
Rennel, E.S.2
Qiu, Y.3
Bevan, H.S.4
Perrin, R.M.5
Raffy, S.6
Dixon, A.R.7
Paraskeva, C.8
Zaccheo, O.9
Hassan, A.B.10
Harper, S.J.11
Bates, D.O.12
-
19
-
-
56749179738
-
The alternatively spliced anti-angiogenic family of VEGF isoforms VEGFxxxb in human kidney development
-
Bevan H.S., van den Akker N.M., Qiu Y., Polman J.A., Foster R.R., Yem J., Nishikawa A., Satchell S.C., Harper S.J., Gittenberger-de Groot A.C., Bates D.O.: The alternatively spliced anti-angiogenic family of VEGF isoforms VEGFxxxb in human kidney development. Nephron Physiol. 110: p57-67 (2008)
-
(2008)
Nephron Physiol
, vol.110
, pp. 57-67
-
-
Bevan, H.S.1
van den Akker, N.M.2
Qiu, Y.3
Polman, J.A.4
Foster, R.R.5
Yem, J.6
Nishikawa, A.7
Satchell, S.C.8
Harper, S.J.9
Gittenberger-de Groot, A.C.10
Bates, D.O.11
-
20
-
-
25144511910
-
The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions
-
Takahashi H., Shibuya M.: The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions. Clin Sci (Lond) 109: 227-241 (2005)
-
(2005)
Clin Sci (Lond)
, vol.109
, pp. 227-241
-
-
Takahashi, H.1
Shibuya, M.2
-
21
-
-
0033604614
-
Signaling via vascular endothelial growth factor receptors
-
Petrova T.V., Makinen T., Alitalo K.: Signaling via vascular endothelial growth factor receptors. Exp. Cell Res. 253: 117-130 (1999)
-
(1999)
Exp. Cell Res
, vol.253
, pp. 117-130
-
-
Petrova, T.V.1
Makinen, T.2
Alitalo, K.3
-
22
-
-
0008885761
-
Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells
-
Gospodarowicz D., Abraham J.A., Schilling J.: Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells. Proc. Natl. Acad. Sci. U. S. A. 86: 7311-7315 (1989)
-
(1989)
Proc. Natl. Acad. Sci. U. S. A
, vol.86
, pp. 7311-7315
-
-
Gospodarowicz, D.1
Abraham, J.A.2
Schilling, J.3
-
23
-
-
0027421333
-
Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor
-
Kendall R.L., Thomas K.A.: Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc. Natl. Acad. Sci. U. S. A. 90: 10705-10709 (1993)
-
(1993)
Proc. Natl. Acad. Sci. U. S. A
, vol.90
, pp. 10705-10709
-
-
Kendall, R.L.1
Thomas, K.A.2
-
24
-
-
0031867648
-
Differential binding characteristics and cellular inhibition by soluble VEGF receptors 1 and 2
-
Roeckl W., Hecht D., Sztajer H., Waltenberger J., Yayon A., Weich H.A.: Differential binding characteristics and cellular inhibition by soluble VEGF receptors 1 and 2. Exp. Cell Res. 241: 161-170 (1998)
-
(1998)
Exp. Cell Res
, vol.241
, pp. 161-170
-
-
Roeckl, W.1
Hecht, D.2
Sztajer, H.3
Waltenberger, J.4
Yayon, A.5
Weich, H.A.6
-
25
-
-
0026485002
-
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
-
Shweiki D., Itin A., Softer D., Keshet E.: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359: 843-845 (1992)
-
(1992)
Nature
, vol.359
, pp. 843-845
-
-
Shweiki, D.1
Itin, A.2
Softer, D.3
Keshet, E.4
-
26
-
-
0029039195
-
Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia
-
Levy A.P., Levy N.S., Wegner S., Goldberg M.A.: Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J. Biol. Chem. 270: 13333-13340 (1995)
-
(1995)
J. Biol. Chem
, vol.270
, pp. 13333-13340
-
-
Levy, A.P.1
Levy, N.S.2
Wegner, S.3
Goldberg, M.A.4
-
27
-
-
0029103274
-
Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5′ enhancer
-
Liu Y., Cox S.R., Morita T., Kourembanas S.: Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5′ enhancer. Circ. Res. 77: 638-643 (1995)
-
(1995)
Circ. Res
, vol.77
, pp. 638-643
-
-
Liu, Y.1
Cox, S.R.2
Morita, T.3
Kourembanas, S.4
-
28
-
-
47349117843
-
Selective activation of peroxisome proliferator-activated receptor (PPAR)alpha and PPAR gamma induces neoangiogenesis through a vascular endothelial growth factor-dependent mechanism
-
Biscetti F., Gaetani E., Flex A., Aprahamian T., Hopkins T., Straface G., Pecorini G., Stigliano E., Smith R.C., Angelini F., Castellot J.J., Jr., Pola R.: Selective activation of peroxisome proliferator-activated receptor (PPAR)alpha and PPAR gamma induces neoangiogenesis through a vascular endothelial growth factor-dependent mechanism. Diabetes 57: 1394-1404 (2008)
-
(2008)
Diabetes
, vol.57
, pp. 1394-1404
-
-
Biscetti, F.1
Gaetani, E.2
Flex, A.3
Aprahamian, T.4
Hopkins, T.5
Straface, G.6
Pecorini, G.7
Stigliano, E.8
Smith, R.C.9
Angelini, F.10
Castellot Jr., J.J.11
Pola, R.12
-
29
-
-
0036289551
-
High glucose induced VEGF expression via PKC and ERK in glomerular podocytes
-
Hoshi S., Nomoto K., Kuromitsu J., Tomari S., Nagata M.: High glucose induced VEGF expression via PKC and ERK in glomerular podocytes. Biochem. Biophys. Res. Commun. 290: 177-184 (2002)
-
(2002)
Biochem. Biophys. Res. Commun
, vol.290
, pp. 177-184
-
-
Hoshi, S.1
Nomoto, K.2
Kuromitsu, J.3
Tomari, S.4
Nagata, M.5
-
30
-
-
14044270809
-
Translational regulation of vascular endothelial growth factor expression in renal epithelial cells by angiotensin II
-
Feliers D., Duraisamy S., Barnes J.L., Ghosh-Choudhury G., Kasinath B.S.: Translational regulation of vascular endothelial growth factor expression in renal epithelial cells by angiotensin II. Am. J. Physiol. Renal Physiol. 288: F521-529 (2005)
-
(2005)
Am. J. Physiol. Renal Physiol
, vol.288
-
-
Feliers, D.1
Duraisamy, S.2
Barnes, J.L.3
Ghosh-Choudhury, G.4
Kasinath, B.S.5
-
31
-
-
0345164367
-
Receptors of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in fetal and adult human kidney: Localization and [125I]VEGF binding sites
-
Simon M., Rockl W., Hornig C., Grone E.F., Theis H., Weich H.A., Fuchs E., Yayon A., Grone H.J.: Receptors of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in fetal and adult human kidney: localization and [125I]VEGF binding sites. J. Am. Soc. Nephrol. 9: 1032-1044 (1998)
-
(1998)
J. Am. Soc. Nephrol
, vol.9
, pp. 1032-1044
-
-
Simon, M.1
Rockl, W.2
Hornig, C.3
Grone, E.F.4
Theis, H.5
Weich, H.A.6
Fuchs, E.7
Yayon, A.8
Grone, H.J.9
-
32
-
-
2442707596
-
The role of vascular endothelial growth factor (VEGF) in renal pathophysiology
-
Schrijvers B.F., Flyvbjerg A., De Vriese A.S.: The role of vascular endothelial growth factor (VEGF) in renal pathophysiology. Kidney Int. 65: 2003-2017 (2004)
-
(2004)
Kidney Int
, vol.65
, pp. 2003-2017
-
-
Schrijvers, B.F.1
Flyvbjerg, A.2
De Vriese, A.S.3
-
33
-
-
0033840069
-
Coexpression of neuropilin-1, Flk1, and VEGF(164) in developing and mature mouse kidney glomeruli
-
Robert B., Zhao X., Abrahamson D.R.: Coexpression of neuropilin-1, Flk1, and VEGF(164) in developing and mature mouse kidney glomeruli. Am. J. Physiol. Renal Physiol. 279: F275-282 (2000)
-
(2000)
Am. J. Physiol. Renal Physiol
, vol.279
-
-
Robert, B.1
Zhao, X.2
Abrahamson, D.R.3
-
34
-
-
0034816063
-
Expression of neuropilin-1 by human glomerular epithelial cells in vitro and in vivo
-
Harper S.J., Xing C.Y., Whittle C., Parry R., Gillatt D., Peat D., Mathieson P.W.: Expression of neuropilin-1 by human glomerular epithelial cells in vitro and in vivo. Clin Sci (Lond) 101: 439-446 (2001)
-
(2001)
Clin Sci (Lond)
, vol.101
, pp. 439-446
-
-
Harper, S.J.1
Xing, C.Y.2
Whittle, C.3
Parry, R.4
Gillatt, D.5
Peat, D.6
Mathieson, P.W.7
-
35
-
-
7044260750
-
Podocyte-derived vascular endothelial growth factor mediates the stimulation of alpha3(IV) collagen production by transforming growth factor-beta1 in mouse podocytes
-
Chen S., Kasama Y., Lee J.S., Jim B., Marin M., Ziyadeh F.N.: Podocyte-derived vascular endothelial growth factor mediates the stimulation of alpha3(IV) collagen production by transforming growth factor-beta1 in mouse podocytes. Diabetes 53: 2939-2949 (2004)
-
(2004)
Diabetes
, vol.53
, pp. 2939-2949
-
-
Chen, S.1
Kasama, Y.2
Lee, J.S.3
Jim, B.4
Marin, M.5
Ziyadeh, F.N.6
-
36
-
-
0034809350
-
Effects of filtration rate on the glomerular barrier and clearance of four differently shaped molecules
-
Ohlson M., Sorensson J., Lindstrom K., Blom A.M., Fries E., Haraldsson B.: Effects of filtration rate on the glomerular barrier and clearance of four differently shaped molecules. Am. J. Physiol. Renal Physiol. 281: F103-113 (2001)
-
(2001)
Am. J. Physiol. Renal Physiol
, vol.281
-
-
Ohlson, M.1
Sorensson, J.2
Lindstrom, K.3
Blom, A.M.4
Fries, E.5
Haraldsson, B.6
-
37
-
-
3242749316
-
The role of VEGF-A in glomerular development and function
-
Eremina V., Quaggin S.E.: The role of VEGF-A in glomerular development and function. Curr. Opin. Nephrol. Hypertens. 13: 9-15 (2004)
-
(2004)
Curr. Opin. Nephrol. Hypertens
, vol.13
, pp. 9-15
-
-
Eremina, V.1
Quaggin, S.E.2
-
38
-
-
0038623780
-
Functional evidence that vascular endothelial growth factor may act as an autocrine factor on human podocytes
-
Foster R.R., Hole R., Anderson K., Satchell S.C., Coward R.J., Mathieson P.W., Gillatt D.A., Saleem M.A., Bates D.O., Harper S.J.: Functional evidence that vascular endothelial growth factor may act as an autocrine factor on human podocytes. Am. J. Physiol. Renal Physiol. 284: F1263-1273 (2003)
-
(2003)
Am. J. Physiol. Renal Physiol
, vol.284
-
-
Foster, R.R.1
Hole, R.2
Anderson, K.3
Satchell, S.C.4
Coward, R.J.5
Mathieson, P.W.6
Gillatt, D.A.7
Saleem, M.A.8
Bates, D.O.9
Harper, S.J.10
-
39
-
-
78751575262
-
How increased VEGF induces glomerular hyperpermeability: A potential signaling pathway of Rac1 activation
-
Peng H., Wang C., Ye Z.C., Chen Y.R., Zhang J., Chen Z.J., Yu X.Q., Lou T.Q.: How increased VEGF induces glomerular hyperpermeability: a potential signaling pathway of Rac1 activation. Acta Diabetol.: (2009)
-
(2009)
Acta Diabetol
-
-
Peng, H.1
Wang, C.2
Ye, Z.C.3
Chen, Y.R.4
Zhang, J.5
Chen, Z.J.6
Yu, X.Q.7
Lou, T.Q.8
-
40
-
-
1942502810
-
Regulation of tight junctions and loss of barrier function in pathophysiology
-
Harhaj N.S., Antonetti O.A.: Regulation of tight junctions and loss of barrier function in pathophysiology. Int. J. Biochem. Cell Biol. 36: 1206-1237 (2004)
-
(2004)
Int. J. Biochem. Cell Biol
, vol.36
, pp. 1206-1237
-
-
Harhaj, N.S.1
Antonetti, O.A.2
-
41
-
-
33645456580
-
Vascular endothelial growth factor a signaling in the podocyte-endothelial compartment is required for mesangial cell migration and survival
-
Eremina V., Cui S., Gerber H., Ferrara N., Haigh J., Nagy A., Ema M., Rossant J., Jothy S., Miner J.H., Quaggin S.E.: Vascular endothelial growth factor a signaling in the podocyte-endothelial compartment is required for mesangial cell migration and survival. J. Am. Soc. Nephrol. 17: 724-735 (2006)
-
(2006)
J. Am. Soc. Nephrol
, vol.17
, pp. 724-735
-
-
Eremina, V.1
Cui, S.2
Gerber, H.3
Ferrara, N.4
Haigh, J.5
Nagy, A.6
Ema, M.7
Rossant, J.8
Jothy, S.9
Miner, J.H.10
Quaggin, S.E.11
-
42
-
-
0030927017
-
Vascular endothelial growth factor is an essential molecule for mouse kidney development: Glomerulogenesis and nephrogenesis
-
Kitamoto Y., Tokunaga H., Tomita K.: Vascular endothelial growth factor is an essential molecule for mouse kidney development: glomerulogenesis and nephrogenesis. J. Clin. Invest. 99: 2351-2357 (1997)
-
(1997)
J. Clin. Invest
, vol.99
, pp. 2351-2357
-
-
Kitamoto, Y.1
Tokunaga, H.2
Tomita, K.3
-
43
-
-
0037370325
-
Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases
-
Eremina V., Sood M., Haigh J., Nagy A., Lajoie G., Ferrara N., Gerber H.P., Kikkawa Y., Miner J.H., Quaggin S.E.: Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J. Clin. Invest. 111: 707-716 (2003)
-
(2003)
J. Clin. Invest
, vol.111
, pp. 707-716
-
-
Eremina, V.1
Sood, M.2
Haigh, J.3
Nagy, A.4
Lajoie, G.5
Ferrara, N.6
Gerber, H.P.7
Kikkawa, Y.8
Miner, J.H.9
Quaggin, S.E.10
-
44
-
-
0037631361
-
Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria
-
Sugimoto H., Hamano Y., Charytan D., Cosgrove D., Kieran M., Sudhakar A., Kalluri R.: Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria. J. Biol. Chem. 278: 12605-12608 (2003)
-
(2003)
J. Biol. Chem
, vol.278
, pp. 12605-12608
-
-
Sugimoto, H.1
Hamano, Y.2
Charytan, D.3
Cosgrove, D.4
Kieran, M.5
Sudhakar, A.6
Kalluri, R.7
-
45
-
-
0037373006
-
Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia
-
Maynard S.E., Min J.Y., Merchan J., Lim K.H., Li J., Mondai S., Libermann T.A., Morgan J.P., Sellke F.W., Stillman I.E., Epstein F.H., Sukhatme V.P., Karumanchi S.A.: Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J. Clin. Invest. 111: 649-658 (2003)
-
(2003)
J. Clin. Invest
, vol.111
, pp. 649-658
-
-
Maynard, S.E.1
Min, J.Y.2
Merchan, J.3
Lim, K.H.4
Li, J.5
Mondai, S.6
Libermann, T.A.7
Morgan, J.P.8
Sellke, F.W.9
Stillman, I.E.10
Epstein, F.H.11
Sukhatme, V.P.12
Karumanchi, S.A.13
-
46
-
-
74049106975
-
-
Greek source
-
Greek source
-
-
-
-
47
-
-
40849130173
-
VEGF inhibition and renal thrombotic microangiopathy
-
Eremina V., Jefferson J.A., Kowalewska J., Hochster H., Haas M., Weisstuch J., Richardson C., Kopp J.B., Kabir M.G., Backx P.H., Gerber H.P., Ferrara N., Barisoni L., Alpers C.E., Quaggin S.E.: VEGF inhibition and renal thrombotic microangiopathy. N. Engl. J. Med. 358: 1129-1136 (2008)
-
(2008)
N. Engl. J. Med
, vol.358
, pp. 1129-1136
-
-
Eremina, V.1
Jefferson, J.A.2
Kowalewska, J.3
Hochster, H.4
Haas, M.5
Weisstuch, J.6
Richardson, C.7
Kopp, J.B.8
Kabir, M.G.9
Backx, P.H.10
Gerber, H.P.11
Ferrara, N.12
Barisoni, L.13
Alpers, C.E.14
Quaggin, S.E.15
-
48
-
-
33846638744
-
Risks of proteinuria and hypertension with bevacizumab, an antibody against vascular endothelial growth factor: Systematic review and meta-analysis
-
Zhu X., Wu S., Dahut W.L., Parikh C.R.: Risks of proteinuria and hypertension with bevacizumab, an antibody against vascular endothelial growth factor: systematic review and meta-analysis. Am. J. Kidney Dis. 49: 186-193 (2007)
-
(2007)
Am. J. Kidney Dis
, vol.49
, pp. 186-193
-
-
Zhu, X.1
Wu, S.2
Dahut, W.L.3
Parikh, C.R.4
-
49
-
-
0032589378
-
VEGF(165) mediates glomerular endothelial repair
-
Ostendorf T., Kunter U., Eitner F., Loos A., Regele H., Kerjaschki D., Henninger D.D., Janjic N., Floege J.: VEGF(165) mediates glomerular endothelial repair. J. Clin. Invest. 104: 913-923 (1999)
-
(1999)
J. Clin. Invest
, vol.104
, pp. 913-923
-
-
Ostendorf, T.1
Kunter, U.2
Eitner, F.3
Loos, A.4
Regele, H.5
Kerjaschki, D.6
Henninger, D.D.7
Janjic, N.8
Floege, J.9
-
50
-
-
34447265300
-
Increased expression of vascular endothelial growth factor in kidney leads to progressive impairment of glomerular functions
-
Liu E., Morimoto M., Kitajima S., Koike T., Yu Y., Shiiki H., Nagata M., Watanabe T., Fan J.: Increased expression of vascular endothelial growth factor in kidney leads to progressive impairment of glomerular functions. J. Am. Soc. Nephrol. 18: 2094-2104 (2007)
-
(2007)
J. Am. Soc. Nephrol
, vol.18
, pp. 2094-2104
-
-
Liu, E.1
Morimoto, M.2
Kitajima, S.3
Koike, T.4
Yu, Y.5
Shiiki, H.6
Nagata, M.7
Watanabe, T.8
Fan, J.9
-
51
-
-
33947217234
-
Impaired glomerular maturation and lack of VEGF165b in Denys-Drash syndrome
-
Schumacher V.A., Jeruschke S., Eitner F., Becker J.U., Pitschke G., Ince Y., Miner J.H., Leuschner I., Engers R., Everding A.S., Bulla M., Royer-Pokora B.: Impaired glomerular maturation and lack of VEGF165b in Denys-Drash syndrome. J. Am. Soc. Nephrol. 18: 719-729 (2007)
-
(2007)
J. Am. Soc. Nephrol
, vol.18
, pp. 719-729
-
-
Schumacher, V.A.1
Jeruschke, S.2
Eitner, F.3
Becker, J.U.4
Pitschke, G.5
Ince, Y.6
Miner, J.H.7
Leuschner, I.8
Engers, R.9
Everding, A.S.10
Bulla, M.11
Royer-Pokora, B.12
-
52
-
-
0032712434
-
Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes
-
Cooper M.E., Vranes D., Youssef S., Stacker S.A., Cox A.J., Rizkalla B., Casley D.J., Bach L.A., Kelly D.J., Gilbert R.E.: Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes. Diabetes 48: 2229-2239 (1999)
-
(1999)
Diabetes
, vol.48
, pp. 2229-2239
-
-
Cooper, M.E.1
Vranes, D.2
Youssef, S.3
Stacker, S.A.4
Cox, A.J.5
Rizkalla, B.6
Casley, D.J.7
Bach, L.A.8
Kelly, D.J.9
Gilbert, R.E.10
-
53
-
-
0037154304
-
Decreased cardiac expression of vascular endothelial growth factor and its receptors in insulin-resistant and diabetic States: A possible explanation for impaired collateral formation in cardiac tissue
-
Chou E., Suzuma I., Way K.J., Opland D., Clermont A.C., Naruse K., Suzuma K., Bowling N.L., Vlahos C.J., Aiello L.P., King G.L.: Decreased cardiac expression of vascular endothelial growth factor and its receptors in insulin-resistant and diabetic States: a possible explanation for impaired collateral formation in cardiac tissue. Circulation 105: 373-379 (2002)
-
(2002)
Circulation
, vol.105
, pp. 373-379
-
-
Chou, E.1
Suzuma, I.2
Way, K.J.3
Opland, D.4
Clermont, A.C.5
Naruse, K.6
Suzuma, K.7
Bowling, N.L.8
Vlahos, C.J.9
Aiello, L.P.10
King, G.L.11
-
54
-
-
0035034655
-
Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes
-
de Vriese A.S., Tilton R.G., Elger M., Stephan C.C., Kriz W., Lameire N.H.: Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes. J. Am. Soc. Nephrol. 12: 993-1000 (2001)
-
(2001)
J. Am. Soc. Nephrol
, vol.12
, pp. 993-1000
-
-
de Vriese, A.S.1
Tilton, R.G.2
Elger, M.3
Stephan, C.C.4
Kriz, W.5
Lameire, N.H.6
-
55
-
-
58149343883
-
Inducible overexpression of sFlt-1 in podocytes ameliorates glomerulopathy in diabetic mice
-
Ku C.H., White K.E., Dei Cas A., Hayward A., Webster Z., Bilous R., Marshall S., Viberti G., Gnudi L.: Inducible overexpression of sFlt-1 in podocytes ameliorates glomerulopathy in diabetic mice. Diabetes 57: 2824-2833 (2008)
-
(2008)
Diabetes
, vol.57
, pp. 2824-2833
-
-
Ku, C.H.1
White, K.E.2
Dei Cas, A.3
Hayward, A.4
Webster, Z.5
Bilous, R.6
Marshall, S.7
Viberti, G.8
Gnudi, L.9
-
56
-
-
0033782589
-
Vascular endothelial growth factor (VEGF) in children, adolescents and young adults with Type 1 diabetes mellitus: Relation to glycaemic control and microvascular complications
-
Chiarelli F., Spagnoli A., Basciani F., Tumini S., Mezzetti A., Cipollone F., Cuccurullo F., Morgese G., Verrotti A.: Vascular endothelial growth factor (VEGF) in children, adolescents and young adults with Type 1 diabetes mellitus: relation to glycaemic control and microvascular complications. Diabet. Med. 17: 650-656 (2000)
-
(2000)
Diabet. Med
, vol.17
, pp. 650-656
-
-
Chiarelli, F.1
Spagnoli, A.2
Basciani, F.3
Tumini, S.4
Mezzetti, A.5
Cipollone, F.6
Cuccurullo, F.7
Morgese, G.8
Verrotti, A.9
-
57
-
-
0034091279
-
Elevated vascular endothelial growth factor in type 1 diabetic patients with diabetic nephropathy
-
Hovind P., Tarnow L., Oestergaard P.B., Parving H.H.: Elevated vascular endothelial growth factor in type 1 diabetic patients with diabetic nephropathy. Kidney Int. Suppl. 75: S56-61 (2000)
-
(2000)
Kidney Int. Suppl
, vol.75
-
-
Hovind, P.1
Tarnow, L.2
Oestergaard, P.B.3
Parving, H.H.4
-
58
-
-
0034913347
-
Elevated matrix metalloproteinase-2 and -9 in urine, but not in serum, are markers of type 1 diabetic nephropathy
-
Diamant M., Hanemaaijer R., Verheijen J.H., Smit J.W., Radder J.K., Lemkes H.H.: Elevated matrix metalloproteinase-2 and -9 in urine, but not in serum, are markers of type 1 diabetic nephropathy. Diabet. Med. 18: 423-424 (2001)
-
(2001)
Diabet. Med
, vol.18
, pp. 423-424
-
-
Diamant, M.1
Hanemaaijer, R.2
Verheijen, J.H.3
Smit, J.W.4
Radder, J.K.5
Lemkes, H.H.6
-
59
-
-
0031723794
-
Serum levels of basic fibroblast growth factor and vascular endothelial growth factor in children and adolescents with type 1 diabetes mellitus
-
Malamitsi-Puchner A., Sarandakou A., Tziotis J., Dafogianni C., Bartsocas C.S.: Serum levels of basic fibroblast growth factor and vascular endothelial growth factor in children and adolescents with type 1 diabetes mellitus. Pediatr. Res. 44: 873-875 (1998)
-
(1998)
Pediatr. Res
, vol.44
, pp. 873-875
-
-
Malamitsi-Puchner, A.1
Sarandakou, A.2
Tziotis, J.3
Dafogianni, C.4
Bartsocas, C.S.5
-
60
-
-
0032888010
-
Vascular endothelial growth factor mRNA expression in minimal change, membranous, and diabetic nephropathy demonstrated by non-isotopic in situ hybridisation
-
Bailey E., Bottomley M.J., Westwell S., Pringle J.H., Furness P.N., Feehally J., Brenchley P.E., Harper S.J.: Vascular endothelial growth factor mRNA expression in minimal change, membranous, and diabetic nephropathy demonstrated by non-isotopic in situ hybridisation. J. Clin. Pathol. 52: 735-738 (1999)
-
(1999)
J. Clin. Pathol
, vol.52
, pp. 735-738
-
-
Bailey, E.1
Bottomley, M.J.2
Westwell, S.3
Pringle, J.H.4
Furness, P.N.5
Feehally, J.6
Brenchley, P.E.7
Harper, S.J.8
-
61
-
-
0028848487
-
Expression of vascular endothelial growth factor in renal vascular disease and renal allografts
-
Grone H.J., Simon M., Grone E.F.: Expression of vascular endothelial growth factor in renal vascular disease and renal allografts. J. Pathol. 177: 259-267 (1995)
-
(1995)
J. Pathol
, vol.177
, pp. 259-267
-
-
Grone, H.J.1
Simon, M.2
Grone, E.F.3
-
62
-
-
0034608948
-
Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice
-
Ziyadeh F.N., Hoffman B.B., Han D.C., Iglesias-De La Cruz M.C., Hong S.W., Isono M., Chen S., McGowan T.A., Sharma K.: Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice. Proc. Natl. Acad. Sci. U. S. A. 97: 8015-8020 (2000)
-
(2000)
Proc. Natl. Acad. Sci. U. S. A
, vol.97
, pp. 8015-8020
-
-
Ziyadeh, F.N.1
Hoffman, B.B.2
Han, D.C.3
Iglesias-De La Cruz, M.C.4
Hong, S.W.5
Isono, M.6
Chen, S.7
McGowan, T.A.8
Sharma, K.9
-
63
-
-
0033007062
-
Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195
-
Tsuchida K., Makita Z., Yamagishi S., Atsumi T., Miyoshi H., Obara S., Ishida M., Ishikawa S., Yasumura K., Koike T.: Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195. Diabetologia 42: 579-588 (1999)
-
(1999)
Diabetologia
, vol.42
, pp. 579-588
-
-
Tsuchida, K.1
Makita, Z.2
Yamagishi, S.3
Atsumi, T.4
Miyoshi, H.5
Obara, S.6
Ishida, M.7
Ishikawa, S.8
Yasumura, K.9
Koike, T.10
-
64
-
-
0036144851
-
Podocyte injury promotes progressive nephropathy in zucker diabetic fatty rats
-
Hoshi S., Shu Y., Yoshida F., Inagaki T., Sonoda J., Watanabe T., Nomoto K., Nagata M.: Podocyte injury promotes progressive nephropathy in zucker diabetic fatty rats. Lab. Invest. 82: 25-35 (2002)
-
(2002)
Lab. Invest
, vol.82
, pp. 25-35
-
-
Hoshi, S.1
Shu, Y.2
Yoshida, F.3
Inagaki, T.4
Sonoda, J.5
Watanabe, T.6
Nomoto, K.7
Nagata, M.8
-
65
-
-
0036789207
-
Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody
-
Flyvbjerg A., Dagnaes-Hansen F., De Vriese A.S., Schrijvers B.F., Tilton R.G., Rasch R.: Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody. Diabetes 51: 3090-3094 (2002)
-
(2002)
Diabetes
, vol.51
, pp. 3090-3094
-
-
Flyvbjerg, A.1
Dagnaes-Hansen, F.2
De Vriese, A.S.3
Schrijvers, B.F.4
Tilton, R.G.5
Rasch, R.6
-
66
-
-
31544433941
-
A neutralizing VEGF antibody prevents glomerular hypertrophy in a model of obese type 2 diabetes, the Zucker diabetic fatty rat
-
Schrijvers B.F., Flyvbjerg A., Tilton R.G., Lameire N.H., De Vriese A.S.: A neutralizing VEGF antibody prevents glomerular hypertrophy in a model of obese type 2 diabetes, the Zucker diabetic fatty rat. Nephrol. Dial. Transplant. 21: 324-329 (2006)
-
(2006)
Nephrol. Dial. Transplant
, vol.21
, pp. 324-329
-
-
Schrijvers, B.F.1
Flyvbjerg, A.2
Tilton, R.G.3
Lameire, N.H.4
De Vriese, A.S.5
-
67
-
-
33750713086
-
Blockade of vascular endothelial growth factor signaling ameliorates diabetic albuminuria in mice
-
Sung S.H., Ziyadeh F.N., Wang A., Pyagay P.E., Kanwar Y.S., Chen S.: Blockade of vascular endothelial growth factor signaling ameliorates diabetic albuminuria in mice. J. Am. Soc. Nephrol. 17: 3093-3104 (2006)
-
(2006)
J. Am. Soc. Nephrol
, vol.17
, pp. 3093-3104
-
-
Sung, S.H.1
Ziyadeh, F.N.2
Wang, A.3
Pyagay, P.E.4
Kanwar, Y.S.5
Chen, S.6
-
68
-
-
13944274471
-
Inhibition of vascular endothelial growth factor (VEGF) does not affect early renal changes in a rat model of lean type 2 diabetes
-
Schrijvers B.F., De Vriese A.S., Tilton R.G., Van de Voorde J., Denner L., Lameire N.H., Flyvbjerg A.: Inhibition of vascular endothelial growth factor (VEGF) does not affect early renal changes in a rat model of lean type 2 diabetes. Horm. Metab. Res. 37: 21-25 (2005)
-
(2005)
Horm. Metab. Res
, vol.37
, pp. 21-25
-
-
Schrijvers, B.F.1
De Vriese, A.S.2
Tilton, R.G.3
Van de Voorde, J.4
Denner, L.5
Lameire, N.H.6
Flyvbjerg, A.7
-
69
-
-
0031910237
-
Plasma concentration of immunoreactive vascular endothelial growth factor and its relation to smoking
-
Wasada T., Kawahara R., Katsumori K., Naruse M., Omori Y.: Plasma concentration of immunoreactive vascular endothelial growth factor and its relation to smoking. Metabolism. 47: 27-30 (1998)
-
(1998)
Metabolism
, vol.47
, pp. 27-30
-
-
Wasada, T.1
Kawahara, R.2
Katsumori, K.3
Naruse, M.4
Omori, Y.5
-
70
-
-
77955659622
-
Circulating vascular endothelial growth factor in the normo- and/or microalbuminuric patients with type 2 diabetes mellitus
-
Kubisz P., Chudy P., Stasko J., Galajda P., Holly P., Vysehradsky R., Mokan M.: Circulating vascular endothelial growth factor in the normo- and/or microalbuminuric patients with type 2 diabetes mellitus. Acta Diabetol.: (2009)
-
(2009)
Acta Diabetol
-
-
Kubisz, P.1
Chudy, P.2
Stasko, J.3
Galajda, P.4
Holly, P.5
Vysehradsky, R.6
Mokan, M.7
-
71
-
-
2942542536
-
Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitus
-
Kim N.H., Kim K.B., Kim D.L., Kim S.G., Choi K.M., Baik S.H., Choi D.S., Kang Y.S., Han S.Y., Han K.H., Ji Y.H., Cha D.R.: Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitus. Diabet. Med. 21: 545-551 (2004)
-
(2004)
Diabet. Med
, vol.21
, pp. 545-551
-
-
Kim, N.H.1
Kim, K.B.2
Kim, D.L.3
Kim, S.G.4
Choi, K.M.5
Baik, S.H.6
Choi, D.S.7
Kang, Y.S.8
Han, S.Y.9
Han, K.H.10
Ji, Y.H.11
Cha, D.R.12
-
72
-
-
19944419453
-
Vascular endothelial growth factor (VEGF) and soluble VEGF receptor FLT-1 in diabetic nephropathy
-
Kim N.H., Oh J.H., Seo J.A., Lee K.W., Kim S.G., Choi K.M., Baik S.H., Choi D.S., Kang Y.S., Han S.Y., Han K.H., Ji Y.H., Cha D.R.: Vascular endothelial growth factor (VEGF) and soluble VEGF receptor FLT-1 in diabetic nephropathy. Kidney Int. 67: 167-177 (2005)
-
(2005)
Kidney Int
, vol.67
, pp. 167-177
-
-
Kim, N.H.1
Oh, J.H.2
Seo, J.A.3
Lee, K.W.4
Kim, S.G.5
Choi, K.M.6
Baik, S.H.7
Choi, D.S.8
Kang, Y.S.9
Han, S.Y.10
Han, K.H.11
Ji, Y.H.12
Cha, D.R.13
-
73
-
-
0033851522
-
Role of vascular endothelial growth factor in diabetic nephropathy
-
Cha D.R., Kim N.H., Yoon J.W., Jo S.K., Cho W.Y., Kim H.K., Won N.H.: Role of vascular endothelial growth factor in diabetic nephropathy. Kidney Int. Suppl. 77: S104-112 (2000)
-
(2000)
Kidney Int. Suppl
, vol.77
-
-
Cha, D.R.1
Kim, N.H.2
Yoon, J.W.3
Jo, S.K.4
Cho, W.Y.5
Kim, H.K.6
Won, N.H.7
-
74
-
-
33646501496
-
Local VEGF activity but not VEGF expression is tightly regulated during diabetic nephropathy in man
-
Hohenstein B., Hausknecht B., Boehmer K., Riess R., Brekken R.A., Hugo C.P.: Local VEGF activity but not VEGF expression is tightly regulated during diabetic nephropathy in man. Kidney Int. 69: 1654-1661 (2006)
-
(2006)
Kidney Int
, vol.69
, pp. 1654-1661
-
-
Hohenstein, B.1
Hausknecht, B.2
Boehmer, K.3
Riess, R.4
Brekken, R.A.5
Hugo, C.P.6
-
75
-
-
3242659972
-
Quantitave and qualitative changes in vascular endothelial growth factor gene expression in glomeruli of patients with type 2 diabetes
-
Bortoloso E., Del Prete D., Dalla Vestra M., Gambaro G., Saller A., Antonucci F., Baggio B., Anglani F., Fioretto P.: Quantitave and qualitative changes in vascular endothelial growth factor gene expression in glomeruli of patients with type 2 diabetes. Eur. J. Endocrinol. 150: 799-807 (2004)
-
(2004)
Eur. J. Endocrinol
, vol.150
, pp. 799-807
-
-
Bortoloso, E.1
Del Prete, D.2
Dalla Vestra, M.3
Gambaro, G.4
Saller, A.5
Antonucci, F.6
Baggio, B.7
Anglani, F.8
Fioretto, P.9
-
76
-
-
34249901258
-
Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy
-
Lindenmeyer M.T., Kretzler M., Boucherot A., Berra S., Yasuda Y., Henger A., Eichinger F., Gaiser S., Schmid H., Rastaldi M.P., Schrier R.W., Schlondorff D., Cohen C.D.: Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy. J. Am. Soc. Nephrol., 18: 1765-1776 (2007)
-
(2007)
J. Am. Soc. Nephrol
, vol.18
, pp. 1765-1776
-
-
Lindenmeyer, M.T.1
Kretzler, M.2
Boucherot, A.3
Berra, S.4
Yasuda, Y.5
Henger, A.6
Eichinger, F.7
Gaiser, S.8
Schmid, H.9
Rastaldi, M.P.10
Schrier, R.W.11
Schlondorff, D.12
Cohen, C.D.13
-
77
-
-
33846669530
-
Reduction of VEGF-A and CTGF expression in diabetic nephropathy is associated with podocyte loss
-
Baelde H.J., Eikmans M., Lappin D.W., Doran P.P., Hohenadel D., Brinkkoetter P.T., van der Woude F.J., Waldherr R., Rabelink T.J., de Heer E., Bruijn J.A.: Reduction of VEGF-A and CTGF expression in diabetic nephropathy is associated with podocyte loss. Kidney Int. 71: 637-645 (2007)
-
(2007)
Kidney Int
, vol.71
, pp. 637-645
-
-
Baelde, H.J.1
Eikmans, M.2
Lappin, D.W.3
Doran, P.P.4
Hohenadel, D.5
Brinkkoetter, P.T.6
van der Woude, F.J.7
Waldherr, R.8
Rabelink, T.J.9
de Heer, E.10
Bruijn, J.A.11
-
78
-
-
21644463370
-
Mouse models of diabetic nephropathy
-
Breyer M.D., Bottinger E., Brosius F.C., 3rd, Coffman T.M., Harris R.C., Heilig C.W., Sharma K.: Mouse models of diabetic nephropathy. J. Am. Soc. Nephrol. 16: 27-45 (2005)
-
(2005)
J. Am. Soc. Nephrol
, vol.16
, pp. 27-45
-
-
Breyer, M.D.1
Bottinger, E.2
Brosius 3rd, F.C.3
Coffman, T.M.4
Harris, R.C.5
Heilig, C.W.6
Sharma, K.7
-
79
-
-
0031889548
-
Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: Significance for VEGF measurements and cancer biology
-
Banks R.E., Forbes M.A., Kinsey S.E., Stanley A., Ingham E., Walters C., Selby P.J.: Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology. Br. J. Cancer 77: 956-964 (1998)
-
(1998)
Br. J. Cancer
, vol.77
, pp. 956-964
-
-
Banks, R.E.1
Forbes, M.A.2
Kinsey, S.E.3
Stanley, A.4
Ingham, E.5
Walters, C.6
Selby, P.J.7
-
80
-
-
0032826960
-
Soluble vascular endothelial growth factor in various blood transfusion components
-
Nielsen H.J., Werther K., Mynster T., Brunner N.: Soluble vascular endothelial growth factor in various blood transfusion components. Transfusion (Paris) 39: 1078-1083 (1999)
-
(1999)
Transfusion (Paris)
, vol.39
, pp. 1078-1083
-
-
Nielsen, H.J.1
Werther, K.2
Mynster, T.3
Brunner, N.4
-
81
-
-
7444240909
-
VEGF165b, an inhibitory vascular endothelial growth factor splice variant: Mechanism of action, in vivo effect on angiogenesis and endogenous protein expression
-
Woolard J., Wang W.Y., Bevan H.S., Qiu Y., Morbidelli L., Pritchard-Jones R.O., Cui T.G., Sugiono M., Waine E., Perrin R., Foster R., Digby-Bell J., Shields J.D., Whittles C.E., Mushens R.E., Gillatt D.A., Ziche M., Harper S.J., Bates D.O.: VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in vivo effect on angiogenesis and endogenous protein expression. Cancer Res. 64: 7822-7835 (2004)
-
(2004)
Cancer Res
, vol.64
, pp. 7822-7835
-
-
Woolard, J.1
Wang, W.Y.2
Bevan, H.S.3
Qiu, Y.4
Morbidelli, L.5
Pritchard-Jones, R.O.6
Cui, T.G.7
Sugiono, M.8
Waine, E.9
Perrin, R.10
Foster, R.11
Digby-Bell, J.12
Shields, J.D.13
Whittles, C.E.14
Mushens, R.E.15
Gillatt, D.A.16
Ziche, M.17
Harper, S.J.18
Bates, D.O.19
-
82
-
-
20044362239
-
From the periphery of the glomerular capillary wall toward the center of disease: Podocyte injury comes of age in diabetic nephropathy
-
Wolf G., Chen S., Ziyadeh F.N.: From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy. Diabetes 54: 1626-1634 (2005)
-
(2005)
Diabetes
, vol.54
, pp. 1626-1634
-
-
Wolf, G.1
Chen, S.2
Ziyadeh, F.N.3
|